CMP
MRNA icon

Coston McIsaac & Partners’s Moderna MRNA Stock Holding History

Coston McIsaac & Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Buy
359
+250
+229% +$11.7K ﹤0.01% 487
2025
Q4 		$3K Hold
109
– – ﹤0.01% 719
2025
Q3 		$2K Hold
109
– – ﹤0.01% 724
2025
Q2 		$3K Sell
109
-1,170
-91% -$30.8K ﹤0.01% 663
2025
Q1 		$36K Buy
1,279
+1,160
+975% +$41.2K 0.01% 326
2024
Q4 		$4K Hold
119
– – ﹤0.01% 612
2024
Q3 		$7 Sell
119
-20
-14% -$1.84K ﹤0.01% 556
2024
Q2 		$16K Hold
139
– – 0.01% 406
2024
Q1 		$14K Hold
139
– – ﹤0.01% 437
2023
Q4 		$13K Hold
139
– – ﹤0.01% 449
2023
Q3 		$14K Hold
139
– – 0.01% 424
2023
Q2 		$16K Hold
139
– – 0.01% 442
2023
Q1 		$21K Hold
139
– – 0.01% 394
2022
Q4 		$24 Hold
139
– – 0.01% 383
2022
Q3 		$16K Sell
139
-7
-5% -$1.06K 0.01% 358
2022
Q2 		$21K Buy
+146
New +$20.9K 0.01% 201

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return